ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE was reported 594 times

ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSTOPERATIVE ANALGESIA 1 0.2000
1 BLOOD PRESSURE AMBULATORY DECREASED 1 0.0667
2 ANAESTHESIA ORAL 3 0.0448
3 VTH NERVE INJURY 1 0.0204
4 COMPULSIVE CHEEK BITING 1 0.0196
5 THERAPEUTIC PRODUCT EFFECT PROLONGED 8 0.0177
6 TONGUE NECROSIS 1 0.0137
7 DRUG EFFECT PROLONGED 7 0.0127
8 PARAESTHESIA MUCOSAL 1 0.0108
9 INTRANASAL HYPOAESTHESIA 1 0.0106
10 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
11 POST PROCEDURAL SWELLING 9 0.0082
12 GINGIVAL ULCERATION 4 0.0053
13 INJECTION SITE ULCER 5 0.0053
14 TISSUE INJURY 2 0.0046
15 GINGIVAL DISCOLOURATION 2 0.0037
16 HYPOAESTHESIA EYE 2 0.0034
17 INJECTION SITE PALLOR 1 0.0032
18 CORNEAL REFLEX DECREASED 1 0.0027
19 ORAL MUCOSAL EXFOLIATION 4 0.0026
20 INCISION SITE IMPAIRED HEALING 1 0.0025
21 PROCEDURAL HEADACHE 1 0.0024
22 SYSTOLIC HYPERTENSION 1 0.0023
23 DELAYED RECOVERY FROM ANAESTHESIA 2 0.0021
24 HYPOAESTHESIA ORAL 29 0.0019
25 SOFT TISSUE SWELLING 1 0.0018
26 TRISMUS 9 0.0017
27 ADMINISTRATION SITE PAIN 2 0.0017
28 METAL POISONING 1 0.0017
29 GINGIVAL RECESSION 3 0.0016
30 INJECTION SITE NECROSIS 3 0.0015
31 SOFT TISSUE NECROSIS 1 0.0015
32 INJECTION SITE INFLAMMATION 7 0.0014
33 BRAIN STEM SYNDROME 1 0.0013
34 INADEQUATE ANALGESIA 11 0.0013
35 PROCEDURAL NAUSEA 1 0.0012
36 REACTION TO PRESERVATIVES 1 0.0012
37 MOUTH SWELLING 7 0.0012
38 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
39 PHARYNGEAL HYPOAESTHESIA 1 0.0011
40 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
41 FACIAL SPASM 1 0.0009
42 PALATAL OEDEMA 1 0.0008
43 IATROGENIC INJURY 1 0.0008
44 TONIC CLONIC MOVEMENTS 1 0.0008
45 PHARYNGEAL ULCERATION 1 0.0008
46 ANAESTHETIC COMPLICATION 2 0.0007
47 EXCESSIVE EYE BLINKING 1 0.0007
48 BLOOD PRESSURE IMMEASURABLE 1 0.0007
49 NEURITIS 1 0.0006
50 PARAESTHESIA ORAL 9 0.0006
51 INJECTION SITE INFECTION 2 0.0006
52 ORAL DISORDER 4 0.0005
53 TUNNEL VISION 1 0.0005
54 MULTI-ORGAN DISORDER 1 0.0005
55 GINGIVAL SWELLING 2 0.0005
56 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
57 ISCHAEMIA 2 0.0004
58 BILIRUBIN CONJUGATED INCREASED 1 0.0004
59 BLINDNESS TRANSIENT 3 0.0004
60 EYELID IRRITATION 1 0.0004
61 RETINAL ARTERY OCCLUSION 1 0.0004
62 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
63 GINGIVAL PAIN 3 0.0004
64 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
65 LARYNGOSPASM 1 0.0004
66 LIP BLISTER 1 0.0004
67 NERVE INJURY 4 0.0004
68 ELECTRIC SHOCK SENSATION 1 0.0004
69 OXYGEN SATURATION ABNORMAL 1 0.0004
70 FACIAL PARALYSIS 3 0.0004
71 FACIAL PAIN 3 0.0003
72 MOUTH ULCERATION 7 0.0003
73 DYSAESTHESIA 1 0.0003
74 LARYNGEAL OEDEMA 2 0.0003
75 EYELIDS PRURITUS 1 0.0003
76 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
77 OEDEMA MOUTH 1 0.0003
78 PRODUCT FORMULATION ISSUE 2 0.0003
79 DISCOMFORT 18 0.0003
80 VIITH NERVE PARALYSIS 1 0.0003
81 PAPULE 2 0.0003
82 ANAPHYLACTIC SHOCK 7 0.0003
83 GENERAL SYMPTOM 2 0.0003
84 GINGIVAL DISORDER 1 0.0003
85 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
86 ASPHYXIA 2 0.0002
87 LIP SWELLING 8 0.0002
88 DRUG INEFFECTIVE 308 0.0002
89 ABNORMAL SENSATION IN EYE 1 0.0002
90 SWELLING FACE 15 0.0002
91 PALLOR 6 0.0002
92 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
93 ORAL DISCOMFORT 3 0.0002
94 HYPOAESTHESIA 32 0.0002
95 AGEUSIA 5 0.0002
96 INJECTION SITE DISCOMFORT 2 0.0002
97 CHEILITIS 1 0.0002
98 ERYTHEMA OF EYELID 1 0.0002
99 HYPERTENSIVE CRISIS 2 0.0002
100 NEUROTOXICITY 3 0.0002
101 ODYNOPHAGIA 1 0.0002
102 GANGRENE 1 0.0002
103 INJECTION SITE DISCOLOURATION 2 0.0002
104 BLEPHAROSPASM 1 0.0002
105 INCOHERENT 1 0.0002
106 PRODUCT LABEL ISSUE 1 0.0001
107 INJURY ASSOCIATED WITH DEVICE 3 0.0001
108 PARAESTHESIA 23 0.0001
109 EYE MOVEMENT DISORDER 1 0.0001
110 PROCEDURAL PAIN 4 0.0001
111 BURNING SENSATION 10 0.0001
112 BLINDNESS UNILATERAL 2 0.0001
113 DRUG EFFECT INCOMPLETE 5 0.0001
114 CEREBRAL DISORDER 1 0.0001
115 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
116 ATRIOVENTRICULAR BLOCK 1 0.0001
117 NASAL DISCOMFORT 1 0.0001
118 RHINITIS 1 0.0001
119 HYPERAESTHESIA 1 0.0001
120 PRODUCT CONTAINER ISSUE 1 0.0001
121 OROPHARYNGEAL DISCOMFORT 1 0.0001
122 SPUTUM DISCOLOURED 1 0.0001
123 DIZZINESS POSTURAL 1 0.0001
124 PHARYNGEAL SWELLING 1 0.0001
125 EMPHYSEMA 1 0.0001
126 DRY THROAT 1 0.0001
127 TOOTH ABSCESS 1 0.0001
128 RENAL PAIN 1 0.0001
129 IMPAIRED HEALING 3 0.0001
130 ANGIOEDEMA 4 0.0001
131 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
132 GLOSSODYNIA 2 0.0001
133 SCAB 1 0.0001
134 EYELID OEDEMA 1 0.0001
135 MYOCLONUS 1 0.0001
136 SECRETION DISCHARGE 1 0.0001
137 PULMONARY CONGESTION 1 0.0001
138 THROAT TIGHTNESS 2 0.0001
139 ANAPHYLACTIC REACTION 4 0.0001
140 APHONIA 1 0.0001
141 BRONCHOSPASM 1 0.0001
142 BONE LOSS 1 0.0001
143 INJECTION SITE SWELLING 5 0.0001
144 INJECTION SITE PAIN 20 0.0001
145 PHARYNGEAL OEDEMA 1 0.0001
146 SWELLING 6 0.0001
147 ARRHYTHMIA 3 0.0001
148 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
149 EXPIRED PRODUCT ADMINISTERED 2 0.0001
150 INFLAMMATION 3 0.0001
151 LOCAL SWELLING 1 0.0001
152 PRODUCT STORAGE ERROR 5 0.0001
153 COLD SWEAT 1 0.0001
154 TOOTHACHE 1 0.0001
155 PANIC ATTACK 2 0.0001
156 EYE SWELLING 2 0.0001
157 DYSPHAGIA 5 0.0001
158 FEELING JITTERY 1 0.0001
159 POST PROCEDURAL COMPLICATION 1 0.0001
160 CONTUSION 5 0.0001
161 DYSTONIA 1 0.0001
162 EAR PAIN 1 0.0001
163 HEART RATE INCREASED 5 0.0001
164 PRODUCT PHYSICAL ISSUE 1 0.0000
165 TASTE DISORDER 1 0.0000
166 HALLUCINATION, VISUAL 1 0.0000
167 SNEEZING 1 0.0000
168 TINNITUS 2 0.0000
169 SKIN DISCOLOURATION 2 0.0000
170 MUSCLE TWITCHING 1 0.0000
171 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
172 PRESYNCOPE 1 0.0000
173 INJECTION SITE URTICARIA 1 0.0000
174 DIZZINESS 20 0.0000
175 BLOOD PRESSURE INCREASED 6 0.0000
176 RASH GENERALISED 1 0.0000
177 DIPLOPIA 1 0.0000
178 HYPERSENSITIVITY 7 0.0000
179 FEAR 1 0.0000
180 BLOOD BILIRUBIN INCREASED 1 0.0000
181 TREMOR 6 0.0000
182 MENTAL STATUS CHANGES 1 0.0000
183 URTICARIA 6 0.0000
184 PAIN IN JAW 1 0.0000
185 LETHARGY 2 0.0000
186 SEIZURE 4 0.0000
187 NEEDLE ISSUE 1 0.0000
188 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
189 DYSPHONIA 2 0.0000
190 LACRIMATION INCREASED 1 0.0000
191 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
192 EXPOSURE DURING PREGNANCY 2 0.0000
193 NERVOUS SYSTEM DISORDER 1 0.0000
194 LOSS OF CONSCIOUSNESS 4 0.0000
195 EYE DISORDER 1 0.0000
196 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
197 VISUAL ACUITY REDUCED 1 0.0000
198 SYNCOPE 3 0.0000
199 GAIT INABILITY 1 0.0000
200 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
201 PRODUCT QUALITY ISSUE 4 0.0000
202 PAIN 18 0.0000
203 VISION BLURRED 4 0.0000
204 RASH MACULAR 1 0.0000
205 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
206 RESTLESSNESS 1 0.0000
207 DYSGEUSIA 2 0.0000
208 UNEVALUABLE EVENT 2 0.0000
209 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
210 ABORTION SPONTANEOUS 1 0.0000
211 CARDIO-RESPIRATORY ARREST 1 0.0000
212 ROAD TRAFFIC ACCIDENT 1 0.0000
213 MALAISE 10 0.0000
214 LIVER DISORDER 1 0.0000
215 PULMONARY OEDEMA 1 0.0000
216 NO ADVERSE EVENT 4 0.0000
217 SKIN IRRITATION 1 0.0000
218 OROPHARYNGEAL PAIN 2 0.0000
219 RENAL DISORDER 1 0.0000
220 CELLULITIS 1 0.0000
221 FLUSHING 2 0.0000
222 ERYTHEMA 4 0.0000
223 NERVOUSNESS 1 0.0000
224 SPEECH DISORDER 1 0.0000
225 DEPRESSED MOOD 1 0.0000
226 HYPERTENSION 4 0.0000
227 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
228 MEDICATION ERROR 1 0.0000
229 BLISTER 1 0.0000
230 HYPONATRAEMIA 1 0.0000
231 ANXIETY 5 0.0000
232 HERPES ZOSTER 1 0.0000
233 PALPITATIONS 2 0.0000
234 NASAL CONGESTION 1 0.0000
235 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
236 RHINORRHOEA 1 0.0000
237 BLOOD PRESSURE DECREASED 1 0.0000
238 INJECTION SITE REACTION 1 0.0000
239 INJURY 1 0.0000
240 DYSPNOEA 8 0.0000
241 SKIN BURNING SENSATION 1 0.0000
242 MOBILITY DECREASED 1 0.0000
243 RASH 6 0.0000
244 HALLUCINATION 1 0.0000
245 HOT FLUSH 1 0.0000
246 FEELING ABNORMAL 3 0.0000
247 RENAL IMPAIRMENT 1 0.0000
248 SKIN EXFOLIATION 1 0.0000
249 BALANCE DISORDER 1 0.0000
250 ADVERSE DRUG REACTION 1 0.0000
251 SUICIDAL IDEATION 1 0.0000
252 ADVERSE EVENT 1 0.0000
253 MIGRAINE 1 0.0000
254 ATRIAL FIBRILLATION 1 0.0000
255 SOMNOLENCE 2 0.0000
256 CHEST DISCOMFORT 1 0.0000
257 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
258 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
259 MUSCULAR WEAKNESS 1 0.0000
260 VOMITING 4 0.0000
261 EMOTIONAL DISTRESS 1 0.0000
262 OEDEMA PERIPHERAL 1 0.0000
263 INJECTION SITE ERYTHEMA 1 0.0000
264 ASTHENIA 3 0.0000
265 HEADACHE 5 0.0000
266 HYPERHIDROSIS 1 0.0000
267 DEHYDRATION 1 0.0000
268 MEMORY IMPAIRMENT 1 0.0000
269 PERIPHERAL SWELLING 1 0.0000
270 DRUG INTERACTION 1 0.0000
271 CONFUSIONAL STATE 1 0.0000
272 MYALGIA 1 0.0000
273 MYOCARDIAL INFARCTION 1 0.0000
274 MUSCLE SPASMS 1 0.0000
275 CHEST PAIN 1 0.0000
276 GAIT DISTURBANCE 1 0.0000
277 PRURITUS 2 0.0000
278 FATIGUE 4 0.0000
279 NAUSEA 4 0.0000
280 INSOMNIA 1 0.0000
281 WEIGHT DECREASED 1 0.0000
282 COUGH 1 0.0000
283 PAIN IN EXTREMITY 1 0.0000
284 FALL 1 0.0000
285 OFF LABEL USE 1 0.0000